Sucralfate impedes intestinal epithelial sheet migration in a Caco-2 cell culture model

Digestion

Volumn 58, Issue 1, 1997, Pages 34-42

  Emenaker, Nancy J ^a   Dalla, Sandeep ^a   Basson, Mare D ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adhesion; Caco 2; Cell culture; Intestinal mucosa; Peptic ulcer; Restitution; Sucralfate

Indexed keywords

COLLAGEN TYPE 1; SUCRALFATE;

ARTICLE; CELL ADHESION; CELL CULTURE; CELL MOTILITY; CELL STRAIN CACO 2; HUMAN; HUMAN CELL; INTESTINE MUCOSA; PRIORITY JOURNAL;

ANTI-ULCER AGENTS; ANTIBIOTICS, ANTINEOPLASTIC; CACO-2 CELLS; CELL ADHESION; CELL MOVEMENT; COLLAGEN; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INTESTINAL MUCOSA; MITOMYCIN; SUCRALFATE; SUCROSE; WOUND HEALING;

EID: 0031031587     PISSN: 00122823     EISSN: 14219867     Source Type: Journal    
DOI: 10.1159/000201421     Document Type: Article

References (48)

1. Nagashima R: Development of and characteristics of sucralfate. J Clin Gastroenterol 1981: 3(suppl 2): 103-110.
2. Shiau YF, Schenkein JP, Liu HJ, Khouri MR, Watkins JB: Bile salt binding properties of commonly used gastrointestinal drugs: rnaalox. carafate. and questran. J Pharm Sci 1988:77: 527-530.
3. Folkman J, Szabo S, Stovroff M, McNeil P, Li W, Shing Y: Duodenal ulcer. Discovery of a new mechanism and development of angiogenic therapy that accelerates healing. Ann Surg 1991;214:414-425.
4. Basson MD, Modlin IM, Turowski G, Madri JA: Enterocyte-matrix interactions in healing of mucosal injury. Eur J Gastroenterol 1993: 5(suppl 3):21-28.
5. Basson MD, Modlin IM, Flynn SD, Jena BP, Madri JA: Independent modulation of entcro-cyte migration and proliferation by growth factors. matrix proteins, and pharmacologic agents in an in vitro model of mucosal healing. Surgery 1992;112:299-308.
6. Basson MD, Modlin IM, Madri JA: Human enterocylc (Caco-2) migration is modulated in vitro by extracellular matrix composition and epidermal growth factor. J Clin Invest 1992;90: 15-23.
7. Tamawski A, Santos AM, Ichikawa Y, Stachu-ra J, Krause WJ: Development, evolution and healing of experimental gastric ulcers: An overview. Eur J Gastroenterol Hepatol 1993; 5(suppl 3):5-l1.
8. Basson MD, Beidler DR, Turowski G, Zarif A, Modlin IM, Jena BP, Madri JA: Effect of tyrosine kinase inhibition on basal and epidermal growth factor-stimulated human Caco-2 en-terocyte sheet migration and proliferation. J Cell Physiol 1994;160:491-501.
9. Madri JA, Pratt BM, Yannariello-Brown J: Matrix driven cell size changes modulate aortic endothelial cell proliferation and sheet migration. Am J Pathol 1988;132:18-27.
10. Louvard D, Kedinger M, Hauri HP: The differentiating intestinal epithelial cell: Establishment and maintenance functions through interactions between cellular structures. Annu Rev Cell Biol 1992;8:157-195.
11. Peterson MD, Mooseker MS: Characterization of the entcrocyte-like brush border cytoskcle-ton of the C2bb clones of the human intestinal cell line. Caco-2. J Cell Sci 1992:102:581-600.
12. Chantret I, Barbat A, Dussaulx E, Brattain MG, Zweibaum A: Epithelial polarity, villin expression, and enterocytic differentiation of cultured human colon carcinoma cells: A survey of twenty cell lines. Cancer Res 1988:48: 1936-1942.
13. Basson MD, Hong F, Emenaker NJ: Specific modulation of intestinal epithelial brush border enzyme expression by a phorbol ester. J SurgRes 1995;59:121-126.
14. Pcdrazzoli J Jr, Magalhaes AF, Ferraz JG, Trc-visan M, DcNucci G: Triple therapy with sucralfate is not effective in eradicating Helicobacter pylori and does not reduce duodenal ulcer relapse rates. Am J Gastroenterol 1994; 89:1501-1504.
15. Agrawal BK, Prasad RN, Kumar P: A comparative therapeutic trial of sucralfate and ranitidine in initial healing and relapse rate of duodenal ulcer. J Assoc Phvs India 1990:38(suppl 1):720-722.
16. Bianchi Porro G, Lazzaroni M, Barbara L, Co-rinaldesi R, Blasi A, Mangiameli A, Capurso L, Koch M. Cheli R. Bovero E. et al: Famotidine vs. rantidine h.s. in acute duodenal ulcer. A multicentre endoscopic trial. Ital J Gastroenterol 1991;23:65-69.
17. Tarnawski A, Hollander D, Gergely H: The mechanism of protective, therapeutic, and prophylactic actions of sucralfate. Scand J Gastroenterol 1987; 140(suppl):7-13.
18. Hollander D: Peptic disease treatment: Sucralfate and cytoprotection in the 1980s. Am J Med 1989;86(suppl 6A):I52-153.
19. Salim AS: Sulphydryl-containing agents stimulate the healing of duodenal ulceration in man. Pharmacology 1992:45:17-80.
20. Archimandritis A, Charitopoulos N, Diaman-tis T, Kitis G, Kokozidis G, Malias E, Tjivras M: Comparison of sucralfate and ranitidine twice daily in duodenal ulcer treatment: A mul-ticentcr randomized double-blind study. J Clin Gastroenterol 1991;13:380-383.
21. Bianchi Porro G, Parentc F, Lazzaroni M: Short and long term outcome of Helicobacter pylori positive resistant duodenal ulcers treated with colloidal bismuth subcitratc plus antibiotics or sucralfate alone. Gut 1993:34:466-469.
22. Garcia-Paredes J, Dia Rubio M, Llenas F, Tax-onera C, Pardo L: Comparison of sucralfate and ranitidine in the treatment of duodenal ulcers. Am J Med 1991 ;91 (suppl 2A):64-67.
23. Valenzuela IE, Berlin RG, Snape WJ, Johnson TL, Hirschowitz BI, Colon-Pagan J, Morse RS. Pctrozza J. Van Deventer GM, Cagliola A. el al: US experience with omeprazole in duodenal ulcer. Multicenter double-blind comparative study with ranitidine. The Omeprazole DU Comparative Study Group. Dig Dis Sci 1991: 36:762-768.
24. Yap CK, Chong YY, Chia SC, Fock KM: Nizatidine versus cimetidine in the treatment of duodenal ulcers. Ann Acad Med Singapore 1991;20:241-243.
25. Dobrilla G, dePretis G, Chilovi F, Combcrlalo M: Oxmctidine in the short term treatment of active duodenal ulcer. A review and commentary. Scand J Gastroenterol 1989; 167(suppl): 71-80.
26. Bardhan KD, Lee FI, Bose K, Hinchliffe RF, Morris P, Thompson M, Whittaker L. Hardman M. Maxton DG. Colin R. et al: A comparison of cnprostil and ranitidine in treatment of duodenal ulcer. J Clin Gastroenterol 1988:10: 137-142.
27. Weberg R, Aubert E, Dahlbcrg O, Dybdahl J, Ellekjacr E, Farup PG, Hovdenak N, Lange O. Melsom M. Stallemo A. et al: Low-dose antacids or cimetidine for duodenal ulcer? Gastroenterology 1988;95:1465-1469.
28. Kucik DF, Kuo SC, Elson EL, Shcctz MP: Preferential attachment of membrane glycoproteins to the cvtoskeleton at the leading edge of lamella. J Cell Biol 1991:114:1029-1036.
29. Guo M, Toda K, Grinell F: Activation of human keratinoeytc migration on type 1 collagen and fibronectin. J Cell Sci 1990:96:197-205.
30. Lacy ER: Epithelial restitution in the gastrointestinal tract. J Clin Gastroenterol I988(supp! 10):72-77.
31. Kolcga J: The movement of cell clusters in vitro: morphology and directionality. J Cell Sci 1981:49:15-32.
32. Nusrat A, Delp C, Madara JL: Intestinal epithelial restitution. Characterization of a cell culture model and mapping of cytoskeletal elements in migrating cells. J Clin Invest 1992:89: 1501-1511.
33. Tranquillo RT, Murray JD: Mechanistic model of wound contraction. JSurg Res 1993:55:233-247.
34. Tarnawski A, Santos AM, Ichikawa Y, Stachu-ra J, Krause WJ: Development, evolution and healing of experimental gastric ulcers: An overview. Eur J Gastroenterol 1993:5(suppl 3):5-11.
35. Turowski GA, Rashid R, Hong F, Madri JA, Basson MD: Glutamine modulates phenotype and stimulates proliferation in human colon cancer cell lines. Cancer Res 1994:54:5974-5980.
36. Tarnawski A, Hollander D, Sarfeh J, Krause WJ, Eltorai M, Dabros W. et al: Vascular and microvascular changes - Key factors in the development of acetic acid-induced gastric ulcers in rats. J Clin Gastroenterol 1990; 12(suppl 1): 148-157.
37. Tarnawski A, Santos AM, Hanke S, Stachura J, Douglass TG, Sarfeh IJ: Quality of gastric ulcer healing. Is it influenced by antiulccr drugs? Scand J Gastroenterol I995:30(supp! 208):9-13.
38. Dignass AU, Lynch-Devaney K, Podolsky DK: Hcpatocyte growth factor/scatter factor modulates intestinal epithelial cell proliferation and migration. Biochem Biophys Res Commun 1994;202:701-709.
39. Dignass AU, Tsunckawa S, Podolsky DK: Fibroblast growth factors modulate intestinal epithelial cell growth and migration. Gastroenterology 1994:106:1254-1262.
40. Basson MD: Regulation of Intestinal Mucosal Healing by Growth Factors and Matrix Proteins: A Cell Culture Model: PhD diss Yale University Graduate School. 1992.
41. Eliccs MJ, Urry LA, Hemler ME: Receptor functions for the integrin VLA-3:fibroncctin. collagen, and laminin binding arc differentially influenced by Arg-Gly-Asp peptide and by divalent cations. J Cell Biol 1991:112:169-181.
42. Lam SK: Treatment of duodenal ulcer with sucralfate. Scand J Gastroenterol 1991:26 (suppl 185):22-28.
43. Tsukamoto Y, Tsuchida T, Goto H, Hasc S, Arisawa T, Niwa Y: Short report: Effect of sucralfate on angiogencsis in granulation tissue of acetic acid-induced gastric ulcers in rats. Aliment Pharmacol Ther 1993;7:581-584.
44. Mall A, Fourie J, McLeod H, Muschol A, Campbell JA, Hickman R: Administration of sucralfate prolongs survival of animals with experimental peptic ulceration. Am J Med 1991:91 (suppl 2A):37-42.
45. Konturek SJ, Brzozowski T, Drozdowicz D, Garlicki J, Majka J, Pvtko-Polonczyk J: Role of acid milieu in the gastroprotective and ulcer-healing activity of sucralfate. Am J Med 1991 91 (suppl 2A):20-29.
46. Kuwayama H, Matsuo Y, Eastwood GL: Effects of sucralfate, lansoprazole, and cimeli-dine on the delayed healing by hydrocortisone sodium phosphate of chronic gastric ulcers in the rat. Am J Med 1991 ;91 (suppl 2A): 15-19.
47. Madri JA, Basson MD: Extracellular matrix-cell interactions: Dynamic modulators of cell, tissue and organism structure and function. Ub Invest 1992;66:519-521.
48. Tang AS, Chikhalc PJ, Shah PK, Borchardt RT: Utilization of a human intestinal epithelial cell culture system (Caco-2) for evaluat ing cyto-protective agents. Pharmacol Res 1993:10: 1620-1626.